Holen Sie sich die Stockscreener-App
27.75
1.72%
0.47
Handel nachbörslich:
27.75
Schlusskurs vom Vortag:
$27.28
Offen:
$27.86
24-Stunden-Volumen:
279.86K
Relative Volume:
1.08
Marktkapitalisierung:
$1.90B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-48.26M
KGV:
-35.13
EPS:
-0.7899
Netto-Cashflow:
$-45.04M
1W Leistung:
+0.80%
1M Leistung:
-1.67%
6M Leistung:
+71.19%
1J Leistung:
+91.38%
1-Tages-Spanne:
$27.15
$29.05
1-Wochen-Bereich:
$26.75
$29.05
52-Wochen-Spanne:
$11.32
$31.00
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS vs VRTX, REGN, ARGX, RVMD, ALNY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
27.75 | 1.87B | 0 | -48.26M | -45.04M | -0.7899 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-13 | Eingeleitet | Needham | Buy |
| 2025-06-04 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-03-13 | Eingeleitet | Guggenheim | Buy |
| 2025-03-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-02-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-08-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-06-16 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Gh Research Plc Aktie (GHRS) Neueste Nachrichten
GHRS Initiated Coverage by Wells Fargo -- Price Target Announced at $44 - GuruFocus
GH Research PLC (GHRS) Institutional Confidence - TradingKey
GH Research PLC (GHRS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GH Research PLC (GHRS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GH Research PLC (GHRS) Valuation: PE, PB & Fair Value Analysis - TradingKey
GHRS|GH Research PLC|Price:27.280|Chg%:-0.350 - TradingKey
TradingKey - TradingKey
GH Research PLC Revenue Breakdown – NASDAQ:GHRS - TradingView
GH Research PLC (GHRS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GHRS: GH Research PLC Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening - marketscreener.com
GH Research PLC (1KA.DU) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Why is GH Research stock trading higher on Thursday? - MSN
Price-Driven Insight from (GHRS) for Rule-Based Strategy - Stock Traders Daily
Samsara Stock And 2 Founder Led Software Picks With Real Revenue Growth - Sahm
Eli Lilly Drops $3.8 Billion on AtaiBeckley, Sending Psychedelic Stocks Soaring - finance.biggo.com
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time - Finansavisen
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer - Sahm
GHR Research PLC stock hits 52-week high at $30.20 - Investing.com
GHR Research PLC stock hits 52-week high at $30.20 By Investing.com - Investing.com South Africa
GH Research : GHRS - 24/7 Wall St.
Why Is GH Research Stock Trading Higher on Thursday? - Benzinga
Why is GH Research stock surging today? By Investing.com - Investing.com Nigeria
GH Research PLC (GHRS:UW): Stock Price, Quote and News - BNN Bloomberg
Eli Lilly Enters Psychedelic Drug Race With Up to $3.8 Billion AtaiBeckley Deal - finance.biggo.com
Why Psychedelic stocks are surging today - Yahoo Finance UK
GH Research (GHRS) In Focus As FDA Psychedelic Shift Raises The Question Of Value - Sahm
GH Research gains on optimism surrounding potential Eli Lilly-Atai deal (GHRS) - Yahoo Finance
Why is GH Research stock surging today? - Investing.com
GH Research stock jumps on Eli Lilly-Atai acquisition talks By Investing.com - Investing.com Nigeria
GH Research Surges 3.08% as Bullish Momentum Builds Above Key SupportCollar Trade - dars.gov.et
GH Research (GHRS) Declines Over 4% as Stock Tests Key Support LevelsGamma Squeeze - dars.gov.et
A3CUAZ Forecast — Price Target — Prediction for 2027 - TradingView
GH Research (GHRS) price target increased by 18.94% to 40.04 - MSN
GH Research (GHRS) Gains Ground: Bouncing Toward Key Resistance at $28.23Resistance Breakout Stocks - dars.gov.et
Price to sales forward of GH Research PLC – NASDAQ:GHRS - TradingView
Price to book forward of GH Research PLC – NASDAQ:GHRS - TradingView
GHRSGH Research PLC Options - Finviz
GH RESEARCH PLC (GHRS) Stock Chart - ChartMill
AtaiBeckley Stock Outlook Depends on Key Pipeline Catalysts in 2026 - TradingView
Is AtaiBeckley Stock Worth Buying After Its Stronger Rally in 2026? - TradingView
GH Research Plc Actuals & Estimates (FWB:1KA) - TradingView
Pre-Market Movement | GH Research Shares Surge to 52-Week High - 富途牛牛
GHRS Forecast — Price Target — Prediction for 2027 - TradingView
GHRS Stock Price and Chart — NASDAQ:GHRS - TradingView
(GHRS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
GH Research PLC stock hits 52-week high at 25.98 USD - Investing.com
GH Research Shareholders Approve Director Slate and 2026 Auditor at June AGM - TipRanks
GH Research PLC (GHRS) re-elects directors and ratifies PwC Ireland at AGM - Stock Titan
GH Research Plc Actuals & Estimates (MUN:1KA) - TradingView
Finanzdaten der Gh Research Plc-Aktie (GHRS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):